These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 2905645

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pharmacological treatments of tardive dyskinesia in the 1980s.
    Jeste DV, Lohr JB, Clark K, Wyatt RJ.
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):38S-48S. PubMed ID: 3065364
    [Abstract] [Full Text] [Related]

  • 26. Clinical physiology of dopa dyskinesia.
    Hallett M.
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S147-50; discussion S150-3. PubMed ID: 10762142
    [Abstract] [Full Text] [Related]

  • 27. [Clinical pharmacology of dyskinesias induced by L-dopa in Parkinsonian patients].
    Rascol O, Brefel-Courbon C, Blin O.
    Therapie; 1998 Apr; 53(1):43-8. PubMed ID: 9773099
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A summary of current knowledge of tardive dyskinesia.
    Baldessarini RJ.
    Encephale; 1988 Sep; 14 Spec No():263-8. PubMed ID: 2905654
    [Abstract] [Full Text] [Related]

  • 30. Gamma-Acetylenic GABA in tardive dyskinesia.
    Casey DE, Gerlach J, Magelund G, Christensen TR.
    Adv Biochem Psychopharmacol; 1980 Sep; 24():577-80. PubMed ID: 6105803
    [Abstract] [Full Text] [Related]

  • 31. [A double-blind study of the effect of L-dopa in psychotic patients with tardive dyskinesia].
    Karniol IG, Giampietro AC, Moura DS, Vilela WA, Oliveira MA, Zuardi AW.
    Acta Psiquiatr Psicol Am Lat; 1983 Dec; 29(4):261-6. PubMed ID: 6369888
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Diazepam-induced changes in tardive dyskinesia: suggestions for a new conceptual model.
    Singh MM, Becker RE, Pitman RK, Nasrallah HA, Lal H, Dufresne RL, Weber SS, McCalley-Whitters M.
    Biol Psychiatry; 1982 Jun; 17(6):729-42. PubMed ID: 6125219
    [Abstract] [Full Text] [Related]

  • 35. The opioid agonist morphine decreases the dyskinetic response to dopaminergic agents in parkinsonian monkeys.
    Samadi P, Grégoire L, Bédard PJ.
    Neurobiol Dis; 2004 Jun; 16(1):246-53. PubMed ID: 15207281
    [Abstract] [Full Text] [Related]

  • 36. Comparison of intrastriatal administration of noradrenaline and l-DOPA on dyskinetic movements: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine-lesioned rats.
    Buck K, Ferger B.
    Neuroscience; 2009 Mar 03; 159(1):16-20. PubMed ID: 19146929
    [Abstract] [Full Text] [Related]

  • 37. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
    Darmopil S, Martín AB, De Diego IR, Ares S, Moratalla R.
    Biol Psychiatry; 2009 Sep 15; 66(6):603-13. PubMed ID: 19520364
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.